Our pilot study examined the therapeutic potential of adoptively transferred Vδ2 T cells in HIV infection of BLT huMice during cell-associated HIV transmission using CD4+ T cells isolated from ART-treated HIV-positive individuals. This evidence concerns the gene CD4 and HIV infectious disease.